Liraglutide
Liraglutide is a daily GLP-1 receptor agonist with 97% homology to native GLP-1, studied for glucose-dependent insulin secretion and weight loss. Research maps GLP-1R signaling in pancreatic beta cells, gastric emptying delay, and cardiovascular risk biomarkers.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
LL5
Peptide5mg × 10 vials (kit)
$140
LL10
Peptide10mg × 10 vials (kit)
$190
LL30
Peptide30mg × 10 vials (kit)
$330
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord